|
|
||||||||
Exercise Physiology and Metabolism Laboratory, Department of Kinesiology and Health Education, University of Texas, Austin, Texas 78712
Submitted 5 August 2003 ; accepted in final form 6 October 2003
| ABSTRACT |
|---|
|
|
|---|
glucose transporter isoform-4 messenger ribonucleic acid; gene transcription; translation; glucose; streptozocin
Possibly accounting for the increase in glycogen synthesis during the insulin-independent phase is an increase in the permeability of the muscle to glucose (11). As this condition fades, the muscle demonstrates a marked increase in the sensitivity and responsiveness of glucose transport and glycogen synthesis to insulin (4, 10). The magnitude of this increased insulin action can be extremely high and does not appear to reverse completely until glycogen supercompensation has occurred (4, 26).
An adaptation that may contribute to the increase in insulin action and, therefore, increase in glycogen synthesis postexercise is an increase in GLUT-4 protein expression (16, 25). Our laboratory has reported that GLUT-4 mRNA in the skeletal muscle of the rat is significantly increased immediately after prolonged strenuous exercise and that during recovery there is a progressive increase in GLUT-4 protein (16, 17). The increase in GLUT-4 protein, however, was influenced by carbohydrate availability (17). Providing a carbohydrate supplement immediately after exercise caused a downregulation of the GLUT-4 mRNA, but acceleration in GLUT-4 protein expression. Conversely, postexercise fasting resulted in an increase in GLUT-4 mRNA but a slower GLUT-4 protein expression.
The mechanism by which carbohydrate supplementation postexercise downregulates GLUT-4 mRNA and stimulates an increase in GLUT-4 protein expression is unknown but may be mediated by an increase in circulating plasma insulin levels. Insulin has been found to downregulate GLUT-4 mRNA in mammalian cells (8) and to activate mRNA translation via the mitogen-activated protein kinase pathway (15, 18). Therefore, the purpose of the present study was to investigate the role of insulin on skeletal muscle GLUT-4 protein expression and glycogen storage after postexercise carbohydrate supplementation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental design and procedures. Rats were randomly assigned to one of six different treatment groups: sedentary control (Con, n = 6), Con with a prior streptozocin (Stz) treatment (Stz/C, n = 5), immediately postexercise (Ex0, n = 6), Ex0 with a prior Stz treatment (Stz/Ex0, n = 5), 5-h postexercise (Ex5, n = 7), and Ex5 with a prior Stz treatment (Stz/Ex5, n = 5). For all Stz-treated rats, 110 mg/kg of Stz were delivered by intraperitoneal injection, and exercise was performed 72 h after the Stz treatment. Stz was freshly dissolved (25 mg/ml) in a 50 mM citric acid solution before injection. To determine the effect of the Stz treatment on the rats, blood samples were taken from a tail vein and analyzed for glucose. All Stz-treated rats were confirmed as being hyperglycemic before being assigned to a treatment group. The Stz treatment was successful in
70% of the rats. Rats not treated with Stz were injected with vehicle only.
The exercise protocol consisted of two 3-h swimming intervals with a 45-min rest between intervals (25). This protocol was selected because it had previously been found to rapidly increase the muscle GLUT-4 protein concentration (16, 17, 25). The temperature of the water was maintained between 33 and 34°C. All rats swam for 10 min/day for 2 days before the start of the experiment to familiarize them with the exercise environment. This familiarization protocol has no effect on muscle glycogen or GLUT-4 protein concentration (16).
Carbohydrate treatments were administered by oral intubation. Rats from all groups received 0.4 ml of a 50% (wt/vol) glucose solution when the first exercise interval was completed. After the second session of exercise, 1 ml of a 50% (wt/vol) glucose solution was given immediately to all rats, except for those in the Ex0 and Stz/Ex0 groups. Rat chow was continuously supplied ad libitum during the recovery period. Rats from the Ex0 and Stz/Ex0 groups were wrapped in a towel immediately postexercise, and a 0.5-ml blood sample was taken from a tail vein. The rats were then anesthetized in preparation for muscle sampling. Blood samples were taken from the Con, Stz/C, Ex5, and Stz/Ex5 rats 20 min after the final glucose intubation. They were then anesthetized 5 h after completion of the exercise protocol for muscle sampling. All rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (65.0 mg/kg body wt). After muscle sampling, rats were euthanized by cardiac injection of pentobarbital sodium.
Muscle sampling consisted of excising the gastrocnemius of both legs. Fast-twitch red and white sections were rapidly separated over ice and clamped frozen with tongs cooled in liquid N2. These muscle sections were used for glycogen and GLUT-4 protein determination. Fast-twitch red muscle was also used for GLUT-4 mRNA determination.
Plasma glucose and insulin assays. Blood samples were added to 0.1 ml EDTA (24 mg/ml, pH 7.4) and centrifuged for 10 min at 1,000 g, and the plasma was recovered. Plasma glucose was measured with a glucose analyzer (Yellow Springs Instruments 23A, Yellow Springs, OH), and plasma insulin was measured by RIA (Linco, St. Charles, MO).
Glycogen assay. About 50 mg of muscle were dissolved in 1 N KOH at 70°C for 30 min. Dissolved homogenate was neutralized by glacial acetic acid and incubated overnight in acetate buffer (0.3 M sodium acetate, pH to 4.8) containing amyloglucosidase (Boehringer Mannheim, Indianapolis, IN). The reaction mixture was neutralized with 1 N NaOH. Samples were then analyzed by measuring glucosyl units by the Trinder reaction (Sigma, St. Louis, MO).
Glycogen synthase assay. To best approximate the in vivo activity of glycogen synthase, its activity was determined at 30°C in the presence of 7 mmol/l ATP, 100 µmol/l UDP-1-glucose, and varying concentrations of glucose-6-phosphate (G-6-P), as described by Bloch et al. (2). Fast-twitch red gastrocnemius muscle samples were prepared for analysis by homogenization in 5 volumes of 60% glycerol, 50 mmol/l KF, and 20 mmol/l EDTA at pH 7.0 and were further diluted with 8 volumes of 50 mmol/l KF and 20 mmol/l EDTA. In addition to ATP, G-6-P, and UDP-glucose, the reaction buffer contained 50 mmol/l MOPS buffer, 25 mmol/l KF, 20 mmol/l EDTA, 10 mmol/l KH2PO4, and 10 mg/ml glycogen at pH 6.9. An eight-point dose-response curve was performed on four muscle samples from each treatment group, and nonlinear regression analysis was used to distinguish changes in sensitivity from changes in responsiveness under these conditions. Responsiveness was defined as the maximal obtainable G-6-P-stimulated reaction rate at physiological substrate and inhibitory nucleotide concentrations. Sensitivity was defined as the concentration of G-6-P at which half-maximal reaction rate occurred (A0.5). Once activity curves for glycogen synthase were constructed, the activities of glycogen synthase at the A0.5 and in the absence of G-6-P were estimated.
Measurement of GLUT-4 protein concentration. Muscle samples were homogenized (1:20, red muscle and 1:15, white muscle) in 20 mM ice-cold N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 1 mM EDTA, and 250 mM sucrose (hydroxyethyl starch) buffer (pH 7.4) with a Polytron (Brinkman Instruments, Westbury, NY). Sample homogenates and standards were diluted 1:1 with Laemmli sample buffer. Muscle homogenates containing 75 µg (red gastrocnemius) or 100 µg (white gastrocnemius) of protein were then subjected to SDS-polyacrylamide gel electrophoresis run under reducing conditions on a 12.5% resolving gel. Two GLUT-4 standards from rat heart, containing 15 and 30 µg of protein, were loaded in parallel with the muscle samples. Protein determinations were performed on each homogenate via the method of Bradford (3). Resolved proteins were transferred to a polyvinylidene fluoride membrane (Bio-Rad, Hercules, CA), as described previously (16). GLUT-4 antiserum (a gift from Dr. Samuel W. Cushman, NIH) diluted 1:500 was used for immunoblotting. GLUT-4 protein was visualized on hyperfilm using the enhanced chemiluminescence Western Blot Detection Kit (Amersham, Arlington Height, IL), according to the manufacturer's instructions, and the values were made relative to the 30-µg heart standard.
Measurement of GLUT-4 mRNA and ribosomal RNA concentrations. For RNA extraction, muscle tissues were homogenized in guanidium isothiocyanate-
-mercaptoethanol buffer with a Polytron. Total RNA was isolated from frozen tissue samples by the method of Chomczynski and Sacchi (5). For Northern blotting analysis, equal amounts of total RNA (30 µg) were denatured by heating at 60°C for 10 min and separated on 1% agarose-formaldehyde gels. Ethidium bromide staining of the formaldehyde gel and the transferred blots were used for determining the quality of the RNA sample. GLUT-4 mRNA was quantified by dot-blotting analysis. Total RNA samples (4, 2, 1, 0.5, 0.25 µg) were applied directly to a nylon membrane using a vacuum manifold (Bio-Rad, Richmond, CA) and were immobilized by ultraviolet cross-linking. Treatment groups were always analyzed in parallel. An Escherichia coli transfer RNA was used as a control to ensure specific binding of the probe. GLUT-4 mRNA level was determined by hybridization with radioactively labeled GLUT-4 cDNA (a gift from Dr. Morris J. Birnbaum, University of Pennsylvania), as previously described (17). All dot blots were then stripped and reprobed with [32P]5'-end-labeled gene-specific 28S ribosomal RNA oligonucleotide probe and
-actin cDNA (ClonTech, Palo Alto, CA). The amount of GLUT-4 mRNA present in each sample was determined by comparing the intensity of the sample dots with an external GLUT-4 heart standard run on each membrane. Radioactively labeled [
32-P]CTP and [
32-P]ATP were purchased from DuPont-New England Nuclear (Wilmington, DE). Neutral nylon membrane and random primer DNA-labeling kit were purchased from Stratagene (La Jolla, CA).
Statistical analysis. A one-way analysis of variance among the experimental groups was performed on all variables. Fisher's protected least significant differences test, which holds the value of a type I error to 0.05 for each test, was utilized to distinguish significant differences between pairs of groups. A level of P < 0.05 was set for significance for all tests, and all values are expressed as means ± SE.
| RESULTS |
|---|
|
|
|---|
|
|
Glycogen concentrations of fast-twitch red and white muscle are presented in Fig. 3, A and B, respectively. The glycogen concentration of the fast-twitch red muscle, but not the fast-twitch white muscle, of the Stz/C rats was significantly lower than that of the Con rats. Exercise resulted in significant muscle glycogen depletion in both the Ex0 and Stz/Ex0 rats. Glycogen concentrations in red and white fast-twitch muscle were similar for Ex0 and Stz/Ex0 rats. Glycogen concentrations for the Ex5 and Stz/Ex5 rats were determined 5 h after glucose intubation. For the Ex5 rats, fast-twitch red and white muscle glycogen concentrations were 35 and 30% higher than fast-twitch red and white muscle of Con rats, respectively. For the Stz/Ex5 rats, the glycogen concentration of the fast-twitch red muscle was similar to that of the Stz/C rats but significantly lower than that of the Con or Ex5 rats. The glycogen concentration of the fast-twitch white muscle showed little response to glucose intubation in the Stz/Ex5 rats and was significantly lower in the Stz/Ex5 rats compared with the Con but not the Stz/C rats.
|
Fast-twitch red (Fig. 4A) and white (Fig. 4B) muscle GLUT-4 protein concentrations were similar for Con and Stz/C rats, respectively, suggesting that the mild Stz treatment used had no immediate effect on the constitutive expression of muscle GLUT-4 protein. Immediately after exercise, the Ex0 rats exhibited a 30% increase in fast-twitch red and a 21% increase in fast-twitch white muscle GLUT-4 protein. Five hours after glucose intubation, GLUT-4 protein concentration of Ex5 rats was 53 and 47% above Con in fast-twitch red and white muscle, respectively. GLUT-4 protein in muscle of rats exposed to Stz showed no response to exercise (Stz/Ex0) or the combination of exercise and glucose intubation (Stz/Ex5).
|
Glycogen synthase activity and sensitivity to G-6-P was measured in fast-twitch red gastrocnemius muscle (Table 1). Although the Stz-treated rats tended to have a lower maximal glycogen synthase activity than rats not injected with Stz, there was no difference between groups. Furthermore, there was no effect of exercise on maximal activity. Immediately after exercise, the sensitivity of glycogen synthase to allosteric activation, as predicted by the G-6-P A0.5, was significantly increased in Stz-treated and nontreated rats, but there was no difference between groups. There was, however, a difference in the A0.5 between groups before exercise (Con < Stz/C) and 5 h after exercise (Ex5 < Stz/Ex5).
|
Figure 5 illustrates the GLUT-4 mRNA level in fast-twitch red muscle. There was no difference in the GLUT-4 mRNA concentrations of Con and Stz/C rats. Exercise significantly increased muscle GLUT-4 mRNA by
61% in the Ex0 rats. This increase in GLUT-4 mRNA, however, was not observed in the muscle of the Stz/Ex0 rats. Five hours after glucose intubation, the GLUT-4 mRNA concentration of the Ex5 rats was significantly lower than that of the Ex0 rats but 33% above that of the Con rats. In the Stz/Ex5 rats, a slight but significant increase in muscle GLUT-4 mRNA concentration was observed (25% above Stz/C). No differences in 28S ribosomal or
-actin RNA were detected among treatments (data not shown).
|
| DISCUSSION |
|---|
|
|
|---|
To investigate the effects of insulin on GLUT-4 expression, we limited pancreatic insulin secretion by injection of Stz. The injection of Stz resulted in a severely depressed fasting insulin level and the inability of the pancreas to respond to a carbohydrate challenge. Without the normal rise in insulin following carbohydrate supplementation, the fasting blood glucose level was increased fourfold above normal. It was lowered significantly by exercise but still remained approximately threefold above Con. Blood glucose was approximately fivefold above Con 5 h after supplementation.
The inability of the pancreas to maintain a normal insulin concentration had a dramatic effect on exercise-responsive GLUT-4 protein expression. In accordance with our laboratory's earlier research, we found that an acute bout of exercise increased the muscle GLUT-4 protein concentration. The increase in protein was significant immediately postexercise and continued to increase during the 5 h following carbohydrate supplementation. GLUT-4 mRNA was significantly increased immediately after exercise but had declined significantly by 5 h after carbohydrate supplementation. The GLUT-4 response patterns for both fast-twitch red and white muscle were similar. In contrast to the non-Stz rats, rats injected with Stz showed no increase in GLUT-4 mRNA or GLUT-4 protein immediately postexercise. During the 5 h following supplementation, there was a significant rise in GLUT-4 mRNA, but there was still no increase in GLUT-4 protein expression. These results indicate that GLUT-4 protein expression can be rapidly increased by an acute bout of exercise, but that this adaptation requires a physiological insulin concentration.
Our finding that GLUT-4 protein was increasing during the time in which GLUT-4 mRNA was declining suggests that the effect of insulin on GLUT-4 protein expression is regulated in part at the level of translation (17). Insulin has been found to activate mRNA translation via the mitogen-activated protein kinase pathway by initiating the formation of the 40S initiation complex by phosphorylation of the protein PHAS I (18). It has also been found to downregulate GLUT-4 mRNA by inhibiting GLUT-4 gene transcription and reducing GLUT-4 mRNA stability (8), which may explain the downregulation of the GLUT-4 mRNA. However, the finding that the increase in GLUT-4 mRNA in muscle of exercised Stz-treated rats was significantly delayed suggests that insulin has at least a permissive role in the gene transcription process. This could involve the regulation or synthesis of transcription factors required for exercise-induced GLUT-4 gene transcription.
Full expression of the GLUT-4 gene appears to require the concerted interaction of the transcription factors MyoD, myocyte enhancer factor-2 (MEF-2), and the thyroid receptor-
1 (7). Recently, Mora and Pessin (21) reported that nuclear extracts from insulin-deficient rats had reduced binding to the MEF-2 binding site compared with extracts from non-insulin-deficient rats and that insulin deficiency resulted in the down-regulation of the MEF-2 isoform MEF-2A. Replacement of MEF-2A to nuclear extracts from insulin-deficient rats fully restored binding activity of the MEF-2 element. In addition, Zheng et al. (27) reported that the adenosine analog 5-amino-imidazole-4-carboxamide ribonucleoside activates the GLUT-4 gene similar to exercise and that 5-amino-imidazole-4-carboxamide ribonucleoside increased MEF-2 binding to its DNA binding site. It is interesting to note that simply acutely raising plasma insulin levels by carbohydrate supplementation will not result in an increase in GLUT-4 mRNA or protein expression (17). Taken together, this information suggests that insulin deficiency may result in the downregulation of crucial transcription factors such as MEF-2A, which are essential for both exercise and hormonal regulation of GLUT-4 gene expression.
While it is likely that the repressed muscle GLUT-4 protein expression in the Stz rats was due to a reduced insulin concentration, other possibilities exist. First, the Stz rats were hyperglycemic, and, second, they were in all likelihood hyperlipidemic, both of which can cause insulin resistance. However, it is unlikely that the hyperglycemia would have had an effect on GLUT-4 protein expression under the present experimental paradigm. The glucose toxicity that results from hyperglycemia requires a profuse cellular glucose uptake and, therefore, should not have had an effect under the present conditions in which plasma insulin and muscle glucose uptake were suppressed. Similarly, it is unlikely that a high plasma lipid concentration could account for the slow increase in GLUT-4 mRNA and inability of the Stz rats to increase their muscle GLUT-4 protein levels. Animal models that are severely hyperlipidemic, such as the fatty Zucker rat (fa/fa), have normal skeletal muscle GLUT-4 protein concentrations, and their skeletal muscle GLUT-4 protein response to exercise training is normal (1, 9).
With regard to muscle glycogen, Stz treatment caused a reduction in fast-twitch red muscle glycogen but not in fast-twitch white muscle glycogen. After exercise, the difference in muscle glycogen stores between Stz-treated and nontreated rats was eliminated. In Stz-treated rats, carbohydrate supplementation was able to partially return the muscle glycogen stores back to preexercise levels, but only in the nontreated Stz rats was muscle glycogen increased above preexercise levels (glycogen supercompensation). These results agree with earlier studies in which it was reported that insulin is not required for initial restoration of skeletal muscle glycogen stores after a glycogen-depleting exercise but that it is essential for glycogen supercompensation (10, 13, 24).
After a glycogen-depleting exercise, two phases of glycogen resynthesis are typically observed in the rat (10, 13). Immediately after exercise, there is a rapid initial phase of glycogen storage to near normal levels, which can occur in the absence of insulin. This increase in glycogen storage is facilitated by an increase in membrane permeability to glucose due to a protracted increase in glucose transporters incorporated into the plasma membrane during contraction (11, 19) and activation of glycogen synthase as a result of glycogen depletion (6). Thus the increase in glycogen stores in the Stz-treated rats after exercise was likely due to the protracted increase in glucose transport and increase in glycogen synthase activity.
After the insulin-independent effect of exercise on glucose transport subsides, it is replaced by a marked increase in the sensitivity and responsiveness of muscle to insulin (10, 26). This increase in insulin action can be sustained for a prolonged period and does not seem to reverse completely until glycogen supercompensation has occurred (4, 26). The inability of Stztreated rats to glycogen supercompensate was not due to an inability to activate muscle glycogen synthase. Postexercise glycogen synthase activity, as measured by its activity ratio, was significantly increased in both Stz-treated and nontreated rats. Furthermore, the increase in sensitivity of glycogen synthase to activation by G-6-P immediately postexercise was similar in muscle of Stz-treated and nontreated rats and was significantly higher in Stz-treated rats 5 h after carbohydrate supplementation. These results, therefore, suggest that substrate availability was rate limiting for glycogen storage in the Stz-treated rats. Because blood glucose was in excess of 400 mg% in Stz-treated rats after carbohydrate supplementation, substrate availability was likely limited by the inability of the Stz-treated rats to maintain an active muscle glucose transport after the insulin-independent phase of glycogen storage. It may also have been limited by the inability of the Stz-treated rats to increase GLUT-4 protein expression.
In the present study, we observed a rapid increase in GLUT-4 protein expression in skeletal muscle of the rat, which was insulin dependent. Insulin-stimulated muscle glucose transport is increased with increasing GLUT-4 protein concentration (12, 14), which appears to augment the rate and magnitude of glycogen storage after carbohydrate supplementation. In support of this premise is the observation that trained rats, which have an overexpression of muscle GLUT-4 protein, are more capable of storing muscle glycogen than untrained rats (22). Moreover, our laboratory previously found that 16 h after exercise-carbohydrate supplementation, compared with carbohydrate supplementation alone, muscle glycogen of the rat was significantly increased. Exercised rats were found to have a higher muscle GLUT-4 protein concentration, and this difference was found to account for 65% of the variance in glycogen storage (17). These results imply that, during an exercise-carbohydrate supplementation regimen, muscle GLUT-4 expression may directly control the magnitude of glycogen storage by elevating the glucose transport response to insulin stimulation.
In summary, the present findings indicate that the exercise-induced increase in GLUT-4 protein expression requires insulin. Insulin appears to assert its effect at the level of transcription and translation. Although insulin-deficient rats are capable of restoring their muscle glycogen stores to near normal levels in response to carbohydrate feeding postexercise, they are incapable of glycogen supercompensation. This suggests that the exercise-induced increase in GLUT-4 protein expression may be partially responsible for elevated glycogen stores that follow an exercise-carbohydrate supplementation regimen.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
Present address of C.-H. Kuo: Taipei Physical Education College, Taipei, Taiwan.
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. E. Civitarese, M. K. C. Hesselink, A. P. Russell, E. Ravussin, and P. Schrauwen Glucose ingestion during exercise blunts exercise-induced gene expression of skeletal muscle fat oxidative genes Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1023 - E1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Cluberton, S. L. McGee, R. M. Murphy, and M. Hargreaves Effect of carbohydrate ingestion on exercise-induced alterations in metabolic gene expression J Appl Physiol, October 1, 2005; 99(4): 1359 - 1363. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |